Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 09, 2026 01:15 ET | Source: Basilea Pharmaceutica International Ltd, Allschwil

Basilea erhält zusätzliche USD 6 Mio. von CARB-X für die klinische Entwicklung des Antibiotikums BAL2420

Zusage der finanziellen Förderung nach erfolgreichem Abschluss präklinischer Studien und Erhalt der Genehmigung zur Durchführung klinischer Studien Zusätzliche USD 6 Mio. für die erstmalige Erprobung...
April 09, 2026 01:15 ET | Source: Basilea Pharmaceutica International Ltd, Allschwil

Basilea awarded additional CARB-X funding of USD 6 million to support the clinical development of antibiotic BAL2420

Funding is awarded following successful completion of IND-enabling studies and clinical study authorization USD 6 million in additional funding to support antibiotic BAL2420 (LptA inhibitor)...
April 09, 2026 01:15 ET | Source: Novartis Pharma AG

Novartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030

Strengthens three community health models spanning community‑embedded care, earlier intervention and data‑driven population healthScales program footprint from 11 countries to more than 30 by 2030,...
April 09, 2026 01:15 ET | Source: Novartis Pharma AG

Novartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030

Strengthens three community health models spanning community‑embedded care, earlier intervention and data‑driven population healthScales program footprint from 11 countries to more than 30 by 2030,...
April 09, 2026 01:00 ET | Source: Gategroup Finance (Luxembourg) S.A.

Starke Performance 2025: Operative Exzellenz und Marktdynamik als Wachstumstreiber

ZÜRICH, Schweiz, 9. April 2026: Die gategroup Holding AG („gategroup“) hat heute ihren Geschäftsbericht für das zum 31. Dezember 2025 abgeschlossene Geschäftsjahr vorgelegt. In diesem Zeitraum...
April 09, 2026 01:00 ET | Source: Gategroup Finance (Luxembourg) S.A.

Strong performance in 2025, driven by operational excellence and market momentum

Strong performance in 2025: gategroup Holding AG (“gategroup”) today publishes the Annual Report for the financial year ending 31 December 2025.
April 09, 2026 01:00 ET | Source: Idorsia Pharmaceuticals Ltd

Idorsia welcomes Amer Joseph as new Chief Medical Officer and Head of Global Clinical Development

Idorsia thanks Alberto Gimona – most recently Head of Global Clinical Development and Medical Affairs – and wishes him all the best for a well-deserved retirementAmer Joseph joins Idorsia as EVP,...
April 07, 2026 13:00 ET | Source: EPH European Property Holdings PLC

EPH European Property Holdings PLC Profit / Loss Warning - EPH expects net profit in its consolidated accounts for the YE 2025 compared to the previous year

07 April 2026, Limassol, Cyprus / Ad hoc announcement pursuant to Art. 53 LR EPH European Property Holdings PLC (“EPH”, the “Company”) would like to announce that the Company expects a net profit of...
April 03, 2026 02:00 ET | Source: ArcelorMittal S.A.

ArcelorMittal has published a convening notice for its Annual General Meeting and Extraordinary General Meeting of shareholders to be held on 5 May 2026

3 April 2026, 8.00am CET ArcelorMittal (the ‘Company’) announces the publication of the convening notice for its Annual General Meeting and Extraordinary General Meeting of shareholders (the “General...
April 02, 2026 03:00 ET | Source: Kuntarahoitus Oyj

Kuntarahoitus laskee liikkeeseen 50 miljoonan euron nollakuponkisen joukkovelkakirjalainan osana joukkovelkakirjalainaohjelmaa

Kuntarahoitus OyjPörssitiedote2.4.2026 klo 10.00 Kuntarahoitus laskee liikkeeseen 50 miljoonan euron nollakuponkisen joukkovelkakirjalainan osana joukkovelkakirjalainaohjelmaa Kuntarahoitus Oyj...